APA

O'Hare T., Pollock R., Stoffregen E. P., Keats J. A., Abdullah O. M., Moseson E. M., Rivera V. M., Tang H., Metcalf C. A., Bohacek R. S., Wang Y., Sundaramoorthi R., Shakespeare W. C., Dalgarno D., Clackson T., Sawyer T. K., Deininger M. W. & Druker B. J. (20041123). Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML. : Blood.

Chicago

O'Hare Thomas, Pollock Roy, Stoffregen Eric P, Keats Jeffrey A, Abdullah Omar M, Moseson Erika M, Rivera Victor M, Tang Hao, Metcalf Chester A, Bohacek Regine S, Wang Yihan, Sundaramoorthi Raji, Shakespeare William C, Dalgarno David, Clackson Tim, Sawyer Tomi K, Deininger Michael W and Druker Brian J. 20041123. Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML. : Blood.

Harvard

O'Hare T., Pollock R., Stoffregen E. P., Keats J. A., Abdullah O. M., Moseson E. M., Rivera V. M., Tang H., Metcalf C. A., Bohacek R. S., Wang Y., Sundaramoorthi R., Shakespeare W. C., Dalgarno D., Clackson T., Sawyer T. K., Deininger M. W. and Druker B. J. (20041123). Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML. : Blood.

MLA

O'Hare Thomas, Pollock Roy, Stoffregen Eric P, Keats Jeffrey A, Abdullah Omar M, Moseson Erika M, Rivera Victor M, Tang Hao, Metcalf Chester A, Bohacek Regine S, Wang Yihan, Sundaramoorthi Raji, Shakespeare William C, Dalgarno David, Clackson Tim, Sawyer Tomi K, Deininger Michael W and Druker Brian J. Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML. : Blood. 20041123.